Kinnate Biopharma goes public
California-based Kinnate Biopharma, a biopharmaceutical company, has raised $240 million for its IPO after pricing its 12 million shares at $20 per share.
California-based Kinnate Biopharma, a biopharmaceutical company, has raised $240 million for its IPO after pricing its 12 million shares at $20 per share.
Copyright PEI Media
Not for publication, email or dissemination